Alendronate, a double-edged sword acting in the mevalonate pathway

Author：

E-ISSN： 1791-3004|12|3|4238-4242

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.3, 2015-01, pp. : 4238-4242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rb/E2F: A two-edged sword in the melanocytic system

By Halaban Ruth

Cancer and Metastasis Reviews, Vol. 24, Iss. 2, 2005-06 ,pp. : 339-356

Springer Publishing Company

Access to resources Recommend Favorite

Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?

By Tarazona Raquel Casado Javier Soto Rocío DelaRosa Olga Peralbo Esther Rioja Luis Peña José Solana Rafael

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 911-924

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1

By Germano D.

Breast Cancer Research and Treatment, Vol. 67, Iss. 1, 2001-05 ,pp. : 23-33

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1371-1376

Spandidos Publications

Access to resources Recommend Favorite

Double Edge Sword Behavior of Carbendazim: A Potent Fungicide With Anticancer Therapeutic Properties

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 18, Iss. 1, 2018-03 ,pp. : 38-45

Bentham Science Publishers

Access to resources Recommend Favorite